Gainesville, FL, United States of America

Ji-Jing Pang

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji-Jing Pang. Retrieved from https://idiyas.com/inventor/ji-jing-pang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji-Jing Pang: Innovator in Cone Function Restoration

Introduction

Ji-Jing Pang is a notable inventor based in Gainesville, FL (US). She has made significant contributions to the field of genetic therapy, particularly in the restoration of cone function in individuals with cone monochromacies.

Latest Patents

Ji-Jing Pang holds a patent titled "Methods and compositions for restoration of cone function in BCM." This patent includes nucleic acid sequences, recombinant adeno-associated viral particles, compositions, and methods aimed at treating blue cone monochromacy (BCM). The invention specifically utilizes an M-opsin gene that is operably linked to a cone-specific promoter. Additionally, the patent discloses the sequence of a cone-specific PR2.1 promoter.

Career Highlights

Ji-Jing Pang is affiliated with the University of Florida Research Foundation Inc., where she conducts her research and development work. Her innovative approaches have the potential to significantly impact the treatment of visual disorders.

Collaborations

Ji-Jing Pang collaborates with William W Hauswirth, enhancing the research efforts in the field of cone function restoration.

Conclusion

Ji-Jing Pang's work exemplifies the intersection of innovation and medical science, particularly in the area of genetic therapies for vision restoration. Her contributions are paving the way for future advancements in treating visual impairments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…